Breast Cancer, Research and Clinical Trials

Meet the investigator: Donald W. Northfelt, M.D.

By Nicole Ferrara • September 11, 2019

Estimated reading time: 1 minute

At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Donald W. Northfelt, M.D., an oncologist and breast cancer researcher at Mayo Clinic in Phoenix, Arizona, talks about his research, his mentors and promoting equity in clinical trials.

Donald W. Northfelt, M.D.

This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.

Breast Cancer breast cancer cancer clinical trials research Research and Clinical Trials

Request an Appointment

Find a Clinical Trial

New study finds triple-negative breast cancer tumors with an increase in immune cells have lower risk of recurrence after surgery

People with early-stage triple-negative breast cancer and high levels of immune cells in their tumors may have a lower risk of recurrence and better survival rates.